Azathioprin

Azathioprine Struktur
446-86-6
CAS-Nr.
446-86-6
Bezeichnung:
Azathioprin
Englisch Name:
Azathioprine
Synonyma:
IMURAN;muran;Imrel;azamun;azanin;imurek;imurel;Zytrim;Azasan;bw57-322
CBNumber:
CB2170327
Summenformel:
C9H7N7O2S
Molgewicht:
277.26
MOL-Datei:
446-86-6.mol

Azathioprin Eigenschaften

Schmelzpunkt:
243-244°C
Siedepunkt:
521.0±60.0 °C(Predicted)
Dichte
1.5379 (rough estimate)
Brechungsindex
1.7400 (estimate)
storage temp. 
2-8°C
Löslichkeit
Soluble in Dichloromethane and dimethyl sulfoxide.
pka
8.2(at 25℃)
Farbe
Pale-yellow crystals from Me2CO (aq)
Wasserlöslichkeit
<0.1 g/100 mL at 23 ºC
Merck 
14,902
BCS Class
4
Stabilität:
Stable. Incompatible with strong oxidizing agents, strong bases.
InChIKey
LMEKQMALGUDUQG-UHFFFAOYSA-N
CAS Datenbank
446-86-6(CAS DataBase Reference)
IARC
1 (Vol. 26, Sup 7, 100A) 2012
EPA chemische Informationen
Azathioprine (446-86-6)
Sicherheit
  • Risiko- und Sicherheitserklärung
  • Gefahreninformationscode (GHS)
Kennzeichnung gefährlicher Xi,T,Xn
R-Sätze: 45-22-36/37/38-20/21/22
S-Sätze: 53-22-26-36/37-45-36
WGK Germany  3
RTECS-Nr. UO8925000
HazardClass  IRRITANT
HS Code  29339900
Giftige Stoffe Daten 446-86-6(Hazardous Substances Data)
Toxizität LD50 orl-rat: 535 mg/kg NIIRDN 6,3,82
Bildanzeige (GHS) GHS hazard pictogramsGHS hazard pictograms
Alarmwort Achtung
Gefahrenhinweise
Code Gefahrenhinweise Gefahrenklasse Abteilung Alarmwort Symbol P-Code
H302 Gesundheitsschädlich bei Verschlucken. Akute Toxizität oral Kategorie 4 Warnung GHS hazard pictogramssrc="/GHS07.jpg" width="20" height="20" /> P264, P270, P301+P312, P330, P501
H315 Verursacht Hautreizungen. Hautreizung Kategorie 2 Warnung GHS hazard pictogramssrc="/GHS07.jpg" width="20" height="20" /> P264, P280, P302+P352, P321,P332+P313, P362
H319 Verursacht schwere Augenreizung. Schwere Augenreizung Kategorie 2 Warnung GHS hazard pictogramssrc="/GHS07.jpg" width="20" height="20" /> P264, P280, P305+P351+P338,P337+P313P
H335 Kann die Atemwege reizen. Spezifische Zielorgan-Toxizität (einmalige Exposition) Kategorie 3 (Atemwegsreizung) Warnung GHS hazard pictogramssrc="/GHS07.jpg" width="20" height="20" />
H350 Kann Krebs verursachen. Karzinogenität Kategorie 1A Achtung GHS hazard pictogramssrc="/GHS08.jpg" width="20" height="20" />
Sicherheit
P202 Vor Gebrauch alle Sicherheitshinweise lesen und verstehen.
P261 Einatmen von Staub vermeiden.
P301+P312 BEI VERSCHLUCKEN: Bei Unwohlsein GIFTINFORMATIONSZENTRUM/Arzt/... (geeignete Stelle für medizinische Notfallversorgung vom Hersteller/Lieferanten anzugeben) anrufen.
P302+P352 BEI BERÜHRUNG MIT DER HAUT: Mit viel Wasser/... (Hersteller kann, falls zweckmäßig, ein Reinigungsmittel angeben oder, wenn Wasser eindeutig ungeeignet ist, ein alternatives Mittel empfehlen) waschen.
P305+P351+P338 BEI KONTAKT MIT DEN AUGEN: Einige Minuten lang behutsam mit Wasser spülen. Eventuell vorhandene Kontaktlinsen nach Möglichkeit entfernen. Weiter spülen.
P308+P313 BEI Exposition oder falls betroffen: Ärztlichen Rat einholen/ärztliche Hilfe hinzuziehen.

Azathioprin Chemische Eigenschaften,Einsatz,Produktion Methoden

R-Sätze Betriebsanweisung:

R45:Kann Krebs erzeugen.
R22:Gesundheitsschädlich beim Verschlucken.
R36/37/38:Reizt die Augen, die Atmungsorgane und die Haut.
R20/21/22:Gesundheitsschädlich beim Einatmen,Verschlucken und Berührung mit der Haut.

S-Sätze Betriebsanweisung:

S53:Exposition vermeiden - vor Gebrauch besondere Anweisungen einholen.
S22:Staub nicht einatmen.
S26:Bei Berührung mit den Augen sofort gründlich mit Wasser abspülen und Arzt konsultieren.
S36/37:Bei der Arbeit geeignete Schutzhandschuhe und Schutzkleidung tragen.
S45:Bei Unfall oder Unwohlsein sofort Arzt zuziehen (wenn möglich, dieses Etikett vorzeigen).
S36:DE: Bei der Arbeit geeignete Schutzkleidung tragen.

Beschreibung

This immunosuppressive and antineoplastic drug is derived from 6-mercaptopurine. It caused occupational dermatitis in a pharmaceutical worker, reconditioner of old tablet packaging machines and in a production mechanic, working in packaging for a pharmaceutical company.

Chemische Eigenschaften

Azathioprine is a complex heterocyclic compound which forms pale yellow crystals.

Verwenden

An immunosuppressive antimetabolite. Also active as disease modifying antirheumatic drug (DMARD). Azathioprine is a purine analog with immunosuppressive effects.

Definition

ChEBI: A thiopurine that is 6-mercaptopurine in which the mercapto hydrogen is replaced by a 1-methyl-4-nitroimidazol-5-yl group. It is a prodrug for mercaptopurine and is used as an immunosuppressant, prescribed for the treatment of inflammatory conditions and a ter organ transplantation and also for treatment of Crohn's didease and MS.

Indications

Azathioprine (Imuran) is a cytotoxic agent that preferentially destroys any rapidly dividing cell. Since immunologically competent cells are generally rapidly dividing cells, azathioprine is very effective as an immunosuppressive drug. Unfortunately, any cell that is replicating is a target for this action. This lack of specificity leads to serious side effects. Azathioprine, in combination with corticosteroids, has historically been used more widely than any other drug in immunosuppressive therapy. It is classified as a purine antimetabolite and is a derivative of 6-mercaptopurine.

Allgemeine Beschreibung

Pale yellow crystals or yellowish powder. Decomposes at 243-244°C. Used for the treatment of rheumatoid arthritis. A known carcinogen.

Air & Water Reaktionen

Sensitive to oxidation in the air. Insoluble in water.

Reaktivität anzeigen

Azathioprine may react exothermically with acids. Incompatible with isocyanates, peroxides, phenols, epoxides, anhydrides, and acid halides. Hydrolyzed by strongly basic solutions . May react with strong reducing agents to generate flammable gaseous hydrogen or hydrogen sulfide.

Hazard

Confirmed carcinogen.

Brandgefahr

Flash point data for Azathioprine are not available. Azathioprine is probably combustible.

Kontakt-Allergie

This immunosuppressive and antineoplastic drug is derived from 6-mercaptopurine. It caused allergic contact dermatitis in a mother crushing tablets for her leukemic son, and occupational dermatitis in a pharmaceutical reconditioner of old tablet packaging machines, and in a production mechanic working in packaging for a pharmaceutical company.

Mechanism of action

Azathioprine is a phase-specific drug that is toxic to cells during nucleic acid synthesis. Phase-specific drugs are toxic during a specific phase of the mitotic cycle, usually the S-phase, when DNA synthesis is occurring, as opposed to cycle-specific drugs that kill both cycling and intermitotic cells.
Azathioprine is converted in vivo to thioinosinic acid, which competitively inhibits the synthesis of inosinic acid, the precursor to adenylic acid and guanylic acid. In this way, azathioprine inhibits DNA synthesis and therefore suppresses lymphocyte proliferation.This effectively inhibits both humoral and cell-mediated immune responses.

Pharmakologie

Azathioprine is well absorbed following oral administration, with peak blood levels occurring within 1 to 2 hours. It is rapidly and extensively metabolized to 6- mercaptopurine, which is further converted in the liver and erythrocytes to a variety of metabolites, including 6- thiouric acid. Metabolites are excreted in the urine.The half-life of azathioprine and its metabolites in the blood is about 5 hours.

Clinical Use

Azathioprine is a relatively powerful antiinflammatory agent. Although its beneficial effect in various conditions is principally attributable to its direct immunosuppressive action, the antiinflammatory properties of the drug play an important role in its overall therapeutic effectiveness.
Azathioprine has been used widely in combination with corticosteroids to inhibit rejection of organ transplants, particularly kidney and liver allografts. However, it is usually reserved for patients who do not respond to cyclosporine plus corticosteroids alone.
Azathioprine also has applications in certain disorders with autoimmune components, most commonly rheumatoid arthritis. It is as effective as cyclophosphamide in the treatment of Wegener’s granulomatosis. It has largely been replaced by cyclosporine in immunosuppressive therapy. Relative to other cytotoxic agents, the better oral absorption of azathioprine is the reason for its more widespread clinical use.

Nebenwirkungen

The therapeutic use of azathioprine has been limited by the number and severity of adverse effects associated with its administration. Bone marrow suppression resulting in leukopenia, thrombocytopenia, or both may occur. GI toxicity may be a problem. It is also mildly hepatotoxic. Because of its immunosuppressive activity, azathioprine therapy can lead to serious infections. It has been shown to be mutagenic in animals and humans and carcinogenic in animals.

Sicherheitsprofil

Confirmed human carcinogen producing bladder tumors and leukemia. Poison by subcutaneous, intradermal, and intraperitoneal routes. Moderately toxic by ingestion. Human systemic effects: liver changes, hypermotility, diarrhea, nausea or vomiting, increased body temperature, BP lowering, decreased urine volume or anuria, normocytic anemia, bone marrow changes. An experimental teratogen. Other experimental reproductive effects. Human mutation data reported. When heated to decomposition it emits very toxic fumes of NO,xand SOx. An immunosuppressant.

mögliche Exposition

Azathioprine is an immunosuppressive agent, generally used in combination with a corticosteroid to prevent rejection following renal homotransplantations. It also is used following transplantation of other organs. Other uses of azathioprine include the treatment of a variety of presumed autoimmune diseases, including rheumatoid arthritis; ankylosing spondylitis; systemic lupus erythematosus; dermatonyositis, periarteritis nodosa, scleroderma, refractory thombocytopenic purpura; autoimmune hemolytic anemia; chronic active liver disease; regional enteritis; ulcerative colitis; various autoimmune diseases of the eye; acute and chronic glomerulonephritis; the nephritic syndrome; Wegener’s granulomatosis; and multiple sclerosis.

Carcinogenicity

Azathioprine is known to be a human carcinogen based on sufficient evidence of carcinogenicity from studies in humans.

Versand/Shipping

UN2811 Toxic solids, organic, n.o.s., Hazard Class: 6.1; Labels: 6.1-Poisonous materials, Technical Name Required.

Inkompatibilitäten

Incompatible with reducing agents, such as hydrides (may cause the release of explosive gases), oxidizers (chlorates, nitrates, peroxides, permanganates, perchlorates, chlorine, bromine, fluorine, etc.); contact may cause fires or explosions. Keep away from alkaline materials, strong acids (violent exothermic reaction), strong bases.

Azathioprin Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


Azathioprin Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 449)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Shaanxi TNJONE Pharmaceutical Co., Ltd
+8618740459177
sarah@tnjone.com China 1141 58
Capot Chemical Co.,Ltd.
571-85586718 +8613336195806
sales@capotchem.com China 29797 60
Henan Tianfu Chemical Co.,Ltd.
+86-0371-55170693 +86-19937530512
info@tianfuchem.com China 21689 55
Hangzhou FandaChem Co.,Ltd.
008657128800458; +8615858145714
fandachem@gmail.com China 9341 55
career henan chemical co
+86-0371-86658258
sales@coreychem.com China 29914 58
SHANDONG ZHI SHANG CHEMICAL CO.LTD
+86 18953170293
sales@sdzschem.com China 2931 58
Xiamen AmoyChem Co., Ltd
+86-592-6051114 +8618959220845
sales@amoychem.com China 6387 58
Hubei xin bonus chemical co. LTD
86-13657291602
linda@hubeijusheng.com CHINA 22968 58
Chongqing Chemdad Co., Ltd
+86-023-61398051 +8613650506873
sales@chemdad.com China 39916 58
CONIER CHEM AND PHARMA LIMITED
+8618523575427
sales@conier.com China 49391 58

446-86-6(Azathioprin)Verwandte Suche:


  • 6-((1-methyl-4-nitro-1h-imidazol-5-yl)thio)-1h-purin
  • 6-((1-methyl-4-nitroimidazol-5-yl)thio)-purin
  • 6-(1’-methyl-4’-nitro-5’-imidazolyl)-mercaptopurine
  • 6-(1-Methyl-4-nitro-5-imidazolythio)-9H-pur-ine
  • 6-(1-methyl-4-nitroimidazol-5-ylthio)purin
  • 6-(1-methyl-p-nitro-5-imidazolyl)-thiopurine
  • Azathioprine (200 mg)
  • USP30/EP5 API
  • 6-((1-Methyl-4-nitro-1H-iMidazol-5-yl)thio)-7H-purine
  • EP, CEP, USP
  • azamun
  • azanin
  • azathioprineusp
  • bw57-322
  • imurek
  • imurel
  • methylnitroimidazolylmercaptopurine
  • muran
  • nci-c03474
  • nsc-39084
  • AZATHIOPRINE
  • AZATHIOPURINE
  • 6-[(1-methyl-4-nitro-1h-imidazol-5-yl)thio]-1h-purine
  • 6-(1-METHYL-4-NITROIMIDAZOL-5-YL)THIOPURINE
  • 6-(methyl-p-nitro-5-imidazolyl)-thiopurine
  • Azothioprine
  • 6-[(1-Methyl-4-nitro-1H-imidazol-5-yl)thio]-1H-purine, BW-57-322, NSC-39084, Azanin, Imuran, Imurek, Imurel, Zytrim
  • 1H-Purine, 6-(1-methyl-4-nitro-1H-imidazol-5-yl)thio-
  • PURINE,6-((1-METHYL-4-NITROIMIDAZOL-5-YL)THIO)-
  • AZATHIOPRINE[6-(METHYL-P-NITRO-5-IMIDAZOLYL)-THIOPURINE]
  • Zytrim
  • azathioprine crystalline
  • 6-(1-Methyl-4-nitromidazol-5-ylthio)purine
  • 6-(3-Methyl-5-nitroimidazol-4-yl)sulfanyl-7H-purine
  • Imrel
  • 6-[(1-Methyl-4-nitro-1H-imidazol-5-yl)thio]-9H-purine
  • Azasan
  • S-(7H-purin-8-yl)thiohydroxylamine
  • Azathiprine Usp30/Ep5
  • Azathioprine RS
  • Azathioprine >
  • Azathioprine CRS
  • 6-[(1-Methyl-4-nitro-1H-imidazol-5-yl)sulfanyl]-7H-purine
  • 9H-Purine, 6-[(1-methyl-4-nitro-1H-imidazol-5-yl)thio]-
  • Azathioprine USP/EP/BP
  • Azathioprine (BW 57-322)
  • Azathioprine-d3Q: What is Azathioprine-d3 Q: What is the CAS Number of Azathioprine-d3 Q: What is the storage condition of Azathioprine-d3 Q: What are the applications of Azathioprine-d3
  • Azathioprine (1046001)
  • IMURAN
  • Azathioprine, ≥ 98.0%
  • 446-86-6
  • C9H7N7O2S
  • Pharmaceutical intermediates
  • AZANIN
  • Intermediates & Fine Chemicals
  • Pharmaceuticals
  • API's
  • Biochemistry
Copyright 2019 © ChemicalBook. All rights reserved